322 related articles for article (PubMed ID: 11728959)
1. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.
Krüger S; Müller-Steinhardt M; Kirchner H; Kreft B
Am J Kidney Dis; 2001 Dec; 38(6):1264-70. PubMed ID: 11728959
[TBL] [Abstract][Full Text] [Related]
2. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
3. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
McCusker C; Somerville W; Grey V; Mazer B
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
[TBL] [Abstract][Full Text] [Related]
4. A study on the protection of hemodialysis patients against diphtheria and tetanus.
Sagheb MM; Sajjadi S; Sajjady G
Ren Fail; 2009; 31(10):904-9. PubMed ID: 20030525
[TBL] [Abstract][Full Text] [Related]
5. Humoral immunity against hepatitis B, tetanus, and diphtheria following chemotherapy for hematologic malignancies: a report and review of literature.
Alavi S; Rashidi A; Arzanian MT; Shamsian B; Nourbakhsh K
Pediatr Hematol Oncol; 2010 Apr; 27(3):188-94. PubMed ID: 20367262
[TBL] [Abstract][Full Text] [Related]
6. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination.
Krüger S; Seyfarth M; Sack K; Kreft B
Vaccine; 1999 Mar; 17(9-10):1145-50. PubMed ID: 10195626
[TBL] [Abstract][Full Text] [Related]
7. Persistence of humoral immunity to tetanus and diphtheria in hematopoietic stem cell transplant recipients after post-transplant immunization.
Škovránková J; Petráš M
Pediatr Blood Cancer; 2012 Nov; 59(5):908-13. PubMed ID: 22514148
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
Al Aswad IH; Shubair ME
East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
[TBL] [Abstract][Full Text] [Related]
9. [Immunity against diphtheria and tetanus in the adult Polish population].
Walory J; Grzesiowski P; Hryniewicz W
Pol Merkur Lekarski; 2000 Oct; 9(52):687-92. PubMed ID: 11144058
[TBL] [Abstract][Full Text] [Related]
10. Short-term booster effect of diphtheria toxoid in initially long-term protected individuals.
Danilova E; Shiryayev A; Skogen V; Kristoffersen EK; Sjursen H
Vaccine; 2005 Feb; 23(12):1446-50. PubMed ID: 15670879
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
[TBL] [Abstract][Full Text] [Related]
12. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
[TBL] [Abstract][Full Text] [Related]
13. Does vaccination ensure protection? Assessing diphtheria and tetanus antibody levels in a population of healthy children: A cross-sectional study.
Gowin E; Wysocki J; Kałużna E; Świątek-Kościelna B; Wysocka-Leszczyńska J; Michalak M; Januszkiewicz-Lewandowska D
Medicine (Baltimore); 2016 Dec; 95(49):e5571. PubMed ID: 27930568
[TBL] [Abstract][Full Text] [Related]
14. High tetanus and diphtheria antitoxin concentrations in Finnish adults--time for new booster recommendations?
Olander RM; Auranen K; Härkänen T; Leino T
Vaccine; 2009 Aug; 27(39):5295-8. PubMed ID: 19596410
[TBL] [Abstract][Full Text] [Related]
15. Immune response to diphtheria booster vaccine in the Baltic states.
Rønne T; Valentelis R; Tarum S; Griskevica A; Wachmann CH; Aggerbeck H; Plesner AM; Hansen KG; Ricks P
J Infect Dis; 2000 Feb; 181 Suppl 1():S213-9. PubMed ID: 10657217
[TBL] [Abstract][Full Text] [Related]
16. [Immunity against diphtheria and tetanus in various age groups after 40 years since implementation of the mass vaccination program].
Fordymacka A
Przegl Epidemiol; 2000; 54(3-4):333-41. PubMed ID: 11349596
[TBL] [Abstract][Full Text] [Related]
17. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
19. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.
Golaz A; Hardy IR; Glushkevich TG; Areytchiuk EK; Deforest A; Strebel P; Wharton M; Sutter RW
J Infect Dis; 2000 Feb; 181 Suppl 1():S203-7. PubMed ID: 10657215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]